Australian cloud communications provider Symbio has acquired Intrado Australia’s Cisco-focused cloud calling, contact centre and collaboration business to expand its footprint in the unified ...

A hydrogen fuel cell manufacturer backed by three automotive industry heavyweights unwrapped a Class 8 tractor equipped with its powertrain May 16 in its latest step toward attracting North American ...

ANAHEIM, Calif. — Savage Companies will team up with hydrogen fuel cell manufacturer Symbio North America as part of efforts to decarbonize the infrastructure and logistics company’s drayage fleet.

"Symbio's Carrier Infrastructure as a Service offering is designed to provide immediate benefits, with continuous updates to the product suite. As new capabilities and innovations emerge customers ...

If you want to know who really controls Symbio Holdings Limited (ASX:SYM), then you'll have to look at the makeup of its share registry. With 48% stake, individual investors possess the maximum shares ...

AMSTERDAM, July 28, 2023 – Stellantis N.V. confirms it has completed its 33.3% purchase in Symbio, a leader in zero-emission hydrogen mobility. FORVIA and Michelin are equal shareholders. The ...

Project set to advance energy transformation and sustainable development goals through carbon-neutral LNG production serviced by a carbon-neutral natural gas transmission line Expected to reduce ...

Symbio, a Michelin and Faurecia hydrogen company, and Schaeffler have signed an agreement for the creation of a new 50:50 joint venture to produce fuel cell bipolar plates for global mobility and ...

EMERYVILLE, Calif.--(BUSINESS WIRE)--Symbio Robotics, provider of software that automatically powers AI-controlled industrial robots for flexible auto manufacturing – today announced its latest work ...

SymphonHy will enable Symbio to support its customers in making zero-emission hydrogen mobility an affordable reality, without compromising performance. With more than 30 years of experience, the ...

Chimerix to Receive up to $180 Million in Potential Clinical, Regulatory, and Commercial Milestones and is Eligible for Double Digit Royalties “Furthermore, SymBio’s success in transitioning to a ...